Clinical outcome tracking and analysis

Abstract

The described invention provides a system and method for clinical outcome tracking and analysis. The clinical outcome tracking and analysis comprises sorting, outcome tracking, quality of life metrics, toxicity to therapy and cost of care. The system and method includes receiving one or more parameters. Exemplary parameters for sorting include sex, age, ethnicity, comorbidities, tobacco use, source of insurance, medical record number, primary care physician, referring physician, hospital, approved service vendors, disease-specific clinical molecular phenotype, therapy intent, stage of therapy, biomarkers, and cost of care.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application No. 61 / 888,418 (filed October 8, 2013), which is incorporated herein by reference in its entirety. technical field [0003] The present disclosure relates to the treatment of patients with disease, and more particularly to clinical outcome tracking and analysis. Background technique [0004] Healthcare costs associated with aging populations are increasing as the general population is living longer. The costs associated with diseases such as cancer are often enormous. For example, cancer costs are projected to be the highest growth area in health care spending without commensurate improvements in outcomes. In the United States alone, approximately $125 billion was spent on cancer care in 2010, and it is estimated that approximately 15-30% of this spending could be classified as "wasted". Conventional techniques of cost control, such as clinical pathways ...

AI Technical Summary

Problems solved by technology

Conventional techniques of cost control such as clinical pathways and disease management are often ineffective, but there are currently no quality alternatives that currently exist in the market

Images